TROG Annual Scientific Meeting

trog cancer research is pleased to announce the appointment of john cleary to its board. ceo joan torony said that john was a perfect fit for trog’s board as he has more than 20 years’ experience at a senior management and executive level in both the not-for-profit and for-profit indu...

figure>img alt="file 20170816 6110 x12i4u" src="https://cdn.theconversation.com/files/182182/width754/file-20170816-6110-x12i4u.jpg" style="height: 334px; width: 500px;" /> figcaption>patients need to be at the centre of consultations about their treatment. /figure> australian m...

p style="text-align: center;">_ src="/sitefiles/trogcomau/julie_with_mask.jpg" style="height: 338px; width: 600px;" /> trog cancer research is excited to announce julie mccrossin, well-known and respected broadcaster, journalist and former tv host, as its new ambassador. julie has ...

alex carmichael has always been a busy man. during his career he was an executive working for many major australian companies. he's also served as a director of public companies and on the board of many government organisations. he's always been interested in building a better society...

margaret and narelle first met when they were in year four at primary school. the pair have stayed friends since this time and now they are embarking on a trip of a life-time - trekking the wilds of tasmania, raising vital funds for cancer research. margaret and narelle have decide...

patients with advanced skin cancer can now be spared from having to undergo chemotherapy, with results from a new australian study showing that surgery combined with radiotherapy is a more effective treatment. professor sandro porceddu who headed the trog cancer research ‘post’ tri...

westmead hospital is now home to a world-first prostate cancer trial, using revolutionary technology to dramatically slash treatment times. the hospital is the first site in western sydney to run the spark clinical trial. trog's spark trial is underway in several nsw hospitals. it ...

in a brain cancer breakthrough, an international clinical trial , has found that adding temozolomide chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide, significantly improved survival of elderly patients with glioblastoma (gbm), ...

in a world-first breakthrough for early stage low-grade lymphoma, set to change the management of the disease worldwide, an international clinical trial has found that patients live longer when immuno-chemotherapy is combined with radiotherapy. the results of the international phas...